Recruiting at 1 site No phase Huntington Disease

Huntington Disease study: Music Intervention

Official title Study to Evaluate Music Therapy on Irritability and Impulsivity in Patients With Huntington's Disease (MUSIC-HD)

ClinicalTrials.gov ID: NCT06414967

What this study is testing

What it's testing
The study wants to find out if adding music therapy to usual care can lower irritability and impulsivity in people with early Huntington's disease.
Who it's for
People with early‑stage Huntington's disease (about 15 participants).
What's involved
Participants will use a digital music‑therapy program together with their regular treatment and attend study visits for assessments.
Time commitment
The pilot runs for several weeks with regular study visits during that time.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Age \>= 18 years
  • Huntington disease genetically confirmed by the presence of at least 35 repeats of the CAG triplet in exon 1 of the HTT gene
  • UHDRS (Unified Huntington's disease Rating Scale) score \<= 5 with a diagnostic confidence score =4
  • Absence of significant cognitive impairment MoCA \>=24
  • Stable drug therapy in the 28 days prior inclusion and during the study

You likely can't join if

  • Inability to give free and informed consent for study participation
  • Significant hearing impairment
  • Participating to another study the day of enrollement
  • Persons benefiting from enhanced protection, i.e.persons deprived of their liberty by a judicial or administrative decision, adults under legal and...
See the full eligibility criteria
Who can join
  • Age \>= 18 years
  • Huntington disease genetically confirmed by the presence of at least 35 repeats of the CAG triplet in exon 1 of the HTT gene
  • UHDRS (Unified Huntington's disease Rating Scale) score \<= 5 with a diagnostic confidence score =4
  • Absence of significant cognitive impairment MoCA \>=24
  • Stable drug therapy in the 28 days prior inclusion and during the study
  • Without legal tutors or subordination
  • Affiliated to a health insurance system as required by the French law on biomedical research
  • Written informed consent for participation in the study
What rules you out
  • Inability to give free and informed consent for study participation
  • Significant hearing impairment
  • Participating to another study the day of enrollement
  • Persons benefiting from enhanced protection, i.e.persons deprived of their liberty by a judicial or administrative decision, adults under legal and finally patients in a vital emergency situation.

The study team makes the final eligibility decision.

Where it is enrolling

  • Poitiers, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Poitiers, France. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.